Currently out of the existing stock ratings of Kyle Boucher, 5 are a BUY (62.5%), 3 are a HOLD (37.5%).
Analyst Kyle Boucher, currently employed at TD COWEN, has had 63.33% of price targets met with an average potential upside of 29.49%, reached in 55 days on average.
Kyle Boucher has documented 16 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MYGN, Myriad Genetics at 05-Nov-2026.
Analyst best performing recommendations are on TECH (BIO-TECHNE CORP).
The best stock recommendation documented was for TECH (BIO-TECHNE CORP) on 6/23/2026. The price target of $65 was fulfilled within 2 days with a profit of $8.86 (15.78%), with a performance score of 78.91.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 13-Aug-2025
$2.5
1 years 3 months 3 days ago
(13-Aug-2025)
1/5 (20%)
$0.54 (27.55%)
4
Hold Since 27-Feb-2025
$4
1 years 8 months 20 days ago
(27-Feb-2025)
1/2 (50%)
$1.63 (68.78%)
93
Buy Since 13-Mar-2019
$10
$12
4 years 11 months ago
(16-Dec-2021)
0/5 (0%)
$6.21 (163.85%)
Buy Since 07-Aug-2020
$7
$8
5 years 6 months 4 days ago
(12-May-2021)
1/5 (20%)
$1.82 (35.14%)
77
Buy Since 02-Nov-2018
$9
$14
6 years 9 months 5 days ago
(11-Feb-2020)
3/9 (33.33%)
$5.22 (138.10%)
103
Which stock is Kyle Boucher most bullish on?
Which stock is Kyle Boucher most reserved on?
What Year was the first public recommendation made by Kyle Boucher?